Weiss Multi-Strategy Advisers’s Tandem Diabetes Care TNDM Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-142,024	Closed	-$4.2M	–	438
2023 Q4	$4.2M	Buy	142,024 +111,254	+362%	+$2.31M	0.1%	261
2023 Q3	$639K	Sell	30,770 -83,112	-73%	-$2.28M	0.02%	462
2023 Q2	$2.79M	Buy	113,882 +17,929	+19%	+$577K	0.06%	411
2023 Q1	$3.9M	Sell	95,953 -31,073	-24%	-$1.29M	0.09%	308
2022 Q4	$5.71M	Buy	127,026 +104,260	+458%	+$4.72M	0.16%	200
2022 Q3	$1.09M	Buy	22,766 +785	+4%	+$43K	0.03%	485
2022 Q2	$1.3M	Buy	21,981 +11,981	+120%	+$984K	0.04%	457
2022 Q1	$1.16M	Buy	10,000 +2,039	+26%	+$238K	0.03%	481
2021 Q4	$1.2M	Sell	7,961 -2,451	-24%	-$331K	0.03%	453
2021 Q3	$1.24M	Buy	10,412 +225	+2%	+$24.8K	0.03%	474
2021 Q2	$992K	Buy	10,187 +364	+4%	+$32.5K	0.02%	491
2021 Q1	$867K	Sell	9,823 -400	-4%	-$37.2K	0.02%	502
2020 Q4	$978K	Sell	10,223 -848	-8%	-$87.4K	0.02%	493
2020 Q3	$1.26M	Buy	11,071 +1,049	+10%	+$110K	0.03%	401
2020 Q2	$991K	Sell	10,022 -179	-2%	-$14.3K	0.03%	407
2020 Q1	$656K	Sell	10,201 -12,799	-56%	-$897K	0.03%	329
2019 Q4	$1.37M	Buy	23,000 +5,000	+28%	+$308K	0.02%	460
2019 Q3	$1.06M	Hold	18,000	–	–	0.02%	437
2019 Q2	$1.16M	Sell	18,000 -1,000	-5%	-$64.5K	0.03%	366
2019 Q1	$1.21M	Sell	19,000 -16,000	-46%	-$840K	0.03%	373
2018 Q4	$1.33M	Sell	35,000 -67,500	-66%	-$2.38M	0.06%	269
2018 Q3	$4.39M	Sell	102,500 -82,500	-45%	-$2.88M	0.12%	218
2018 Q2	$4.07M	Sell	185,000 -215,000	-54%	-$2.64M	0.1%	254
2018 Q1	$1.98M	Buy	+400,000	New	+$1.29M	0.06%	324
2017 Q4	–	Sell	-2,000	Closed	-$15K	–	658
2017 Q3	$15K	Hold	2,000	–	–	﹤0.01%	469
2017 Q2	$16K	Hold	2,000	–	–	﹤0.01%	506
2017 Q1	$24K	Buy	+2,000	New	+$43.7K	﹤0.01%	535

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TNDM Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 142,024 shares — an estimated $4.2M sold.

Weiss Multi-Strategy Advisers first reported a position in TNDM in Q1 2017 and held it in 27 quarters. The position peaked at $5.71M in Q4 2022. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

Weiss Multi-Strategy Advisers reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 142,024 Tandem Diabetes Care shares in Q1 2024, an estimated $4.2M.
Weiss Multi-Strategy Advisers first reported a position in Tandem Diabetes Care in Q1 2017 and held it in 27 quarters.
Weiss Multi-Strategy Advisers's Tandem Diabetes Care position peaked at $5.71M in Q4 2022.
291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.